Seasonal trading strategies are all about exploiting recurring patterns in investment markets throughout the calendar year. By analyzing historical price trends, investors can aim to capitalize on these trends by buying or selling assets at specific times. One popular example is the adage “Sell in May and Go Away.” This strategy suggests that investors sell… Continue reading Trading Strategies: Seasonal Trading

Whisper numbers are the unofficial and often undisclosed estimates of a company’s earnings per share (EPS) that circulate among investment professionals. Here’s a deeper dive into what they are, their uses, and how reliable they can be: Unofficial and Unreleased: In contrast to the official consensus estimates published by services like First Call, whisper numbers… Continue reading The elusive “Whispered Numbers”

Chipmaker giant NVIDIA’s upcoming earnings report, scheduled for Wednesday, May 22nd after market close, has investors on edge. The company’s impressive history of exceeding expectations is fueling anticipation, but whispers of a potential slowdown have some experts cautious. Analysts are cautiously optimistic. Zacks Investment Research reports a consensus EPS forecast of $5.48, a significant year-over-year… Continue reading NVIDIA Earnings on Deck: Investor Anticipation Hangs in the Balance

Carvana’s stock price surged 40% after a strong first-quarter earnings report. This jump added to the woes of short sellers, who have lost $3.9 billion betting against the company. Carvana’s stock is still far from its all-time high in 2021, but it has rebounded more than 1,500% in the past year. Analysts are mixed on… Continue reading Is Carvana the new Gamestop? Short-Sellers Losses Total $3.9 Billion.

Annovis Bio is a clinical-stage drug platform company founded in 2008. They focus on developing treatments for neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Their approach targets the underlying causes of neurodegeneration by reducing toxic proteins and improving communication between nerve cells. However, things may not be going according to plan… Continue reading Annovis Bio stock plummets 50% amid stage 2 drug results.

Games Workshop, the British miniature wargaming company, is facing a double-headed storm. The company’s recent announcement of a lore retcon – a revision of its established fictional universe – has angered a significant portion of its fanbase. Simultaneously, the company’s stock price has become mysteriously absent from several financial reporting websites. The lore retcon, details… Continue reading Games Workshop’s Lore Retcon Sparks Fan Outrage and Stock Secrecy

The cryptocurrency market’s recent downturn has cast a long shadow, with some dismissing it as a blip and others fearing a full-blown bubble burst. Experts are particularly worried about the echoes of the AI bubble. Both sectors experienced explosive growth fueled by speculation and fervent belief in their transformative potential. Now, as the AI sector… Continue reading Crypto Slump: Correction or Echo of a Burst Bubble?

Artificial intelligence (AI) is the talk of the town. From self-driving cars to market-beating algorithms, it seems AI can do it all. This excitement has certainly translated to the stock market, with companies like NVIDIA hitting record highs. But with whispers of caution from some experts, investors are left wondering: is now the right time… Continue reading AI on the Rise, But Hold Your Horses on Investment?

Gold vs. Bitcoin: A Comparative Analysis In the realm of investments and store of value, gold and Bitcoin represent two vastly different eras. Gold, a tangible asset, has been valued for millennia, while Bitcoin, a digital currency, emerged only a little over a decade ago. This article aims to compare these two assets in terms… Continue reading Gold vs. Bitcoin: A Comparative Analysis